



※ 英文原著論文のみ掲載しています。
【 2008年 】
- Fukagawa M, Yumita S, Akizawa T, Uchida E, Tsukamoto Y, Iwasaki M, Koshikawa S, and KRN1493 study group:
Cinacalcet (KRN 1493) effectively decreases serum intact PTH level with favorable control of serum phohphorus and calcium levels in Japanese dialysis patients.
Nephrol Dial Transplant 23: 328-335, 2008.
- Shiizaki K, Fukagawa M, Yuan Q, Hatamura I, Nii-Kono T, Saji F, Shigematsu T, Akizawa T:
Direct calcitriol or its analogue injection improves abnormal gene expression of hyperplastic parathyroid gland in secondary hyperparathyroidism.
Am J Nephrol 28: 59-66, 2008.
- Fujii H, Hamada Y, Fukagawa M:
Bone formation in the newly established non-obese type 2 diabetic model rats; Spontaneously Diabetic Torii (SDT) rats.
Bone 42: 372-379, 2008.
- Nakai S, Akiba T, Kazama JJ, Yokoyama K, Fukagawa M. Tominaga Y, Iseki K, Tsubakihara Y:
Effects of serum levels of calcium, phosphorus, and intact PTH on survival in chronic hemodialysis patients in Japan.
Ther Aphr Dial 12: 49-54, 2008.
- Hamada Y, Nii-Kono T, Moriguchi Y, Higuchi M, Fukagawa M:
Alteration of duodenal iron absorption in adenine-induced renal failure rats: a possible mechanism of iron deficiency in chronic kidney disease patients with erythropoietin treatment.
Nephrol Dial Transplant 23: 1886-1891, 2008.
- Tsuchihashi D, Abe T, Komaba H, Fujii H, Hamada Y, Nii-Kono T, Tanaka M, Fukagawa M:
Serum hepcidin as an indicator of iron status in dialysis patients.
Ther Aphr Dial 12: 226-231, 2008.
- Fujii H, Takiuchi S, Kawano Y, Fukagawa M:
Putative role of asymmetric dimethylarginine in microvascular disease of kidney and heart in hypertensive patients,
Am J Hypertension 21: 650-656, 2008.
- Fujii H, Fukuda A, Tanaka M, Kojima Y, Ishida T, Hirata K, Fukagawa M:
Putative role of endothelial lipase in cardiovascular disease in dialysis patients with malnutrition and inflammation.
Am J Nephrol 28: 974-981, 2008.
